Topical Treatment for Cutaneous Leishmaniasis – Dermato-Pharmacokinetic Led Optimisation of Benzoxaboroles

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02419-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Topical Formulations of Miltefosine for Cutaneous Leishmaniasis in a BALB/c Mouse Model

Journal of Pharmacy and Pharmacology
PharmacologyPharmaceutical Science
2016English

Erratum to Pharmacokinetic Optimisation of Asthma Treatment

Clinical Pharmacokinetics
Pharmacology
1994English

Cutaneous Leishmaniasis

BMJ
1990English

Randomized, Controlled, Double-Blind Trial of Topical Treatment of Cutaneous Leishmaniasis With Paromomycin Plus Methylbenzethonium Chloride Ointment in Guatemala.

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2001English

Erratum to Pharmacokinetic Optimisation in the Treatment of Parkinson’s Disease

Clinical Pharmacokinetics
Pharmacology
1996English

Recurrent Cutaneous Leishmaniasis

Anais Brasileiros de Dermatologia
Dermatology
2013English

Isoniazid-Resveratrol Cocrystal: A Novel Alternative for Topical Treatment of Cutaneous Tuberculosis

English

Recurrent Diffuse Cutaneous Leishmaniasis

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2012English

Cutaneous Leishmaniasis in Damascus

Eastern Mediterranean Health Journal
Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy